SCHEMBL9122

SCHEMBL9122

O=C(O)CCCC(=O)OC(=O)CCC(=O)C(=O)OC(=O)CCCC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.48
SLC22A6 Q4U2R8 1/20 0.46
LMNA P02545 3/20 0.40
NFKB1 P19838 2/20 0.39
PMP22 Q01453 1/20 0.39
EGLN1 Q9GZT9 2/20 0.36
MAPK1 P28482 1/20 0.36
SLC13A3 Q8WWT9 1/20 0.36
OR51E2 Q9H255 1/20 0.36
CAMK2A Q9UQM7 1/20 0.36
ALDH1A1 P00352 2/20 0.34
GABRR3 A8MPY1 1/20 0.34
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
HDAC3 O15379 1/20 0.34
GABBR2 O75899 1/20 0.34
CYP1A2 P05177 1/20 0.34
THRB P10828 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB1 P18505 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1602470 0.87 SLC22A6 (0.61) TSHRSLC22A6LMNANFKB1PMP22
SCHEMBL6752506 0.85 EGLN1 (0.54) TSHRSLC22A6LMNANFKB1PMP22
SCHEMBL14357996 0.85 TSHR (0.52) TSHRSLC22A6LMNANFKB1PMP22
SCHEMBL11203528 0.84 TSHR (0.58) TSHRSLC22A6LMNANFKB1PMP22
SCHEMBL28058052 0.84 TSHR (0.58) TSHRSLC22A6LMNANFKB1PMP22
SCHEMBL19925 0.84 SLC22A6 (0.65) TSHRSLC22A6LMNANFKB1PMP22
SCHEMBL1289888 0.84 SLC22A6 (0.65) TSHRSLC22A6LMNANFKB1PMP22
Adipic Acid SCHEMBL27504325 0.82 TSHR (0.56) TSHRSLC22A6LMNANFKB1PMP22
Ammonia Solution, Strong SCHEMBL28947727 0.82 TSHR (0.56) TSHRSLC22A6LMNANFKB1PMP22
SCHEMBL2480634 0.82 TSHR (0.56) TSHRSLC22A6LMNANFKB1PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105815313-B Vegetable heavy metal blocking agent and use method thereof 华南农业大学 2018-07-20 CN claimed
WO-2011050211-A2 METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS AGIOS PHARMACEUTICALS, INC. (US) 2011-04-28 WO disclosed
EP-1778616-A1 ALPHA-KETOGLUTARATES AND THEIR USE AS THERAPEUTIC AGENTS Cancer Research Technology Limited (GB) 2007-05-02 EP disclosed
WO-2006016143-A1 ALPHA-KETOGLUTARATES AND THEIR USE AS THERAPEUTIC AGENTS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2006-02-16 WO disclosed